10 ways Dopplex Ablility can help manage Peripheral Arterial Disease (PAD)

Peripheral arterial disease (PAD) is a process that occludes blood flow in limb arteries, which is often asymptomatic1. PAD is a manifestation of systemic atherosclerosis, affecting between 10–15% of the general population.2

DA

A recent Australian study showed that PAD was undiagnosed in 34% of patients, and with further studies estimating approximately 50% of PAD patients are asymptomatic4, 5 leading to under-diagnosis and under-treatment of the disease.6  Both asymptomatic and symptomatic PAD patients have a high risk of death from cardiovascular disease (CVD)7 therefore early treatment reduces mortality.8 

The ankle–brachial pressure index (ABPI) has emerged as a valid and reliable marker of PAD, particularly in patients without clinical features of PAD.9

 

Dopplex Ability

The Dopplex Ability has revolutionised the ABI process and provides automatic, easy, fast and accurate measurements with an immediate printout of results from the integral printer. The Dopplex Ability requires minimal training and provides rapid bilateral ABI measurements in just 3 minutes. Its portability enables measurements to be made more efficiently in the primary care clinic, hospital or patient’s home.

 

10 ways Dopplex Ablility can assist

  1. Extremely easy to use and fully automatic - minimal training required
  2. No need to rest patient for 15mins - reduces total test time
  3. Rapid bi-lateral ABI measurement in 3mins - simultaneous measurements reduces time
  4. ABI can now be undertaken by healthcare support staff - makes the measurement more cost effective
  5. No need to remove patient’s socks or tights - maintains patient comfort and dignity
  6. Easy to apply 4 cuff system - improves patient experience
  7. Portable and powered by mains or rechargeable battery - for home or clinical environments
  8. Integral printer or PC software for documentation of results and waveforms - instant hard copy for patient notes and reimbursement
  9. Automatic classification of ABI - reduces operator error
  10. Accurate reproducible results over a wide range of ABIs - clinically proven by recent studies

 

Where can Dopplex Ability be used?

Wound care – for detecting arterial disease prior to applying compression bandaging

PAD detection – symptomatic or asymptomatic

CHD screening – identifying risk factors

 

Cost Effective

The Dopplex Ability offers a cost effective solution for the measurement of ABI:

  • Rapid measurements in 3mins (Doppler based ABI typically takes 30mins)
  • No need to rest the patient
  • Can be used by healthcare support staff
  • Reduces inappropriate referrals

 

Interested in contacting a product specialist for more information? Contact usDopplex Ability

References

  1. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness and treatment in primary care. JAMA 2001;286:1317–24. Search PubMed
  2. Australian Institute of Health and Welfare. Cardiovascular disease: Australian facts 2011. Cardiovascular disease series. Cat. no. CVD 53. Chapter 8: Peripheral vascular disease, pp. 117–124. Available at aihw.gov.au/publication-detail/ ?id=10737418510 [Accessed 21 March 2013
  3. Prevalence and Outcomes of Undiagnosed Peripheral Arterial Disease Among High Risk Patients in Australia: An Australian REACH Sub-Study Si Si, MBBS, PhDa,f, ,  Jonathan Golledge, MChir, FRACSb Paul Norman, DS, FRACSc Mark Nelson, MBBS, PhDd Derek Chew, MBBS, PhDe Zanfina Ademi, PhDf Deepak L. Bhatt, MD, PhDg Gabriel P. Steg, MD, PhDh Christopher M. Reid, PhDa,f DOI: https://doi.org/10.1016/j.hlc.2018.04.292
  4. Fowkes FGR, Houseley E, Cawood EHH, Macintyre CCA, Ruckley CV, Prescott RJ. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 1991;20:384–92. Search PubMed
  5. Ramos R, Quesada M, Solanas P, et al. Prevalence of symptomatic and asymptomatic peripheral arterial disease and the value of the ankle-brachial index to stratify cardiovascular risk. Eur J Vasc Endovasc Surg 2009;38:305–11. Search PubMed
  6. McDermott MM. The magnitude of the problem of peripheral arterial disease: epidemiology and clinical significance. Cleve Clin J Med 2006;73(Suppl 4):S2–7. Search PubMed
  7. Criqui M, Langer R, Fronek A, et al., Mortality over a period of 10 years in patients with peripheral artery disease. N Engl J Med 1992;326:326–81. Search PubMed
  8. Aung PP, Maxwell HG, Jepson RG, Price JF, Leng GC. Lipid-lowering for peripheral arterial disease of the lower limb. Cochrane Database Syst Rev 2007;4:CD000123. Search PubMed
  9. Zheng Z, Sharrett A, Chambless LE, et al. Associations of ankle–brachial index with clinical coronary heart disease, stroke, and preclinical carotid and popliteal atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis1997; 131: 115-125.